Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination.

Vaccine · 2025 · PMC12286911 · PMID 40311214

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantp = 0.05actually significant

There was a borderline significant difference ( p = 0.05) comparing the COVID >180 days group with the No COVID group.

also in 3,746 other papers

did not reach statistical significanceno p-value reported

There was a trend towards greater potency of viral neutralisation in the COVID <100/7 group, but this did not reach statistical significance. 3.5 The SARS-CoV-2 immunological history of one participant Multiple samples were taken from one participant between November 2020–August 2022.

also in 57,071 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.